SCHEMBL22965397

SCHEMBL22965397

O=C(O)c1c(-c2ccc3c(c2)CCC3)csc1NC(O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.41
KMT2A Q03164 11/20 0.41
RAB9A P51151 1/20 0.40
NLRP3 Q96P20 1/20 0.40
ANO1 Q5XXA6 5/20 0.39
PKM P14618 3/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GRIN2C Q14957 1/20 0.39
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22699633 0.82 KMT2A (0.55) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL21247388 0.82 MEN1 (0.58) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL21247668 0.80 MEN1 (0.58) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL22699591 0.79 ANO1 (0.61) MEN1KMT2AANO1
SCHEMBL22699625 0.78 ANO1 (0.50) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL1952191 0.75 SMN1; SMN2 (0.59) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL1908259 0.74 MEN1 (0.43) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL22699595 0.73 MEN1 (0.51) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL21247347 0.73 MEN1 (0.67) MEN1KMT2ARAB9ANLRP3ANO1
SCHEMBL22965391 0.72 ALDH1A1 (0.35) ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767316-B2 Non-fused thiophene derivatives and their uses ENYO PHARMA (FR) 2023-09-26 US disclosed
US-20210040059-A1 NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES Institut National de la Santé et de la Recherche Médicale (FR) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040059-A1 NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES FTH1, SLC40A1, FECH MEN1 3578/4885KMT2A 3273/4885RAB9A 1953/4885
US-11767316-B2 Non-fused thiophene derivatives and their uses FTH1, SLC40A1, FECH MEN1 3578/4885KMT2A 3273/4885RAB9A 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.